If you are weighing surgery for fuller breasts, two options come up first: breast implants, and fat transfer, which moves fat from one part of your body to your breasts. They are often described as if one is simply the natural version of the other. The evidence shows two different trade-offs.
This article explains how each works, puts the main differences side by side, goes through what FDA and published studies say about risks, and ends with questions worth asking a surgeon. It also covers a third, non-surgical path, because a fair comparison should include it.
A device you add, or tissue you move
Breast implants are manufactured devices placed in the breast, filled with silicone gel or saline. They add volume because the device itself takes up the space.1
Fat transfer uses your own fat, harvested from another area of your body and injected into the breast. Some of the transferred fat is typically lost to resorption, so the volume that stays is less than the volume injected.2
The main differences
What FDA says to know before getting them
FDA's guidance is direct: implants are not considered lifetime devices, and complications become more likely the longer you have them. It lists the complications that occur in at least 1% of patients, including capsular contracture, rupture or deflation, and asymmetry.1
- Silent rupture. Most silicone implant ruptures cause no symptoms. FDA says MRI is the most effective way to find one, and ultrasound is an acceptable alternative.1
- BIA-ALCL. Breast implant-associated anaplastic large cell lymphoma is a T-cell lymphoma that can develop following breast implants.1
- Systemic symptoms. Fatigue, memory loss, rash, “brain fog” and joint pain may be associated with implants, but FDA says these symptoms and their causes are poorly understood, and that some people report relief after removal.1
A history of doubt, and a small evidence base
Fat grafting to the breast was banned in 1987 because of unpredictable graft retention and cysts that could not be told apart from cancer; the restriction was lifted in 2009.3 Today it is generally described as suited to smaller increases.2
One large published series gives a sense of the numbers. It covered 476 patients treated across several centers over nine years, and reported a mean of 346 ml grafted per breast and a mean augmentation of 266 ml per breast at six months or more. No cancers were diagnosed and no biopsies were needed during follow-up, and one patient had a collapsed lung that resolved with temporary drainage.3
Questions worth asking a surgeon
- How many of this exact procedure do you perform, and can I see your own results? Ask for the surgeon's experience, not just before-and-after galleries.
- What will I need over the next 10 to 20 years? For implants, ask about monitoring, replacement and the signs of a problem.
- For fat transfer: do I have enough fat to harvest, and how much volume is realistic after some of it is lost?
- What happens if I am unhappy, or if something goes wrong? Ask about revision and who covers it.
- What imaging or follow-up will I need, and how will it affect screening?
Where a non-surgical option fits
Some people want neither an implant nor an operation. EVEBRA is a third kind of path: it avoids surgery, but it asks for a long daily routine, and results vary. It is not for everyone. It is not for anyone with breast implants, and if you have had fat transfer or other breast surgery you should check with your surgeon and contact the EVEBRA team before starting.
What EVEBRA is and how it works
EVEBRA is a non-surgical breast enlargement system worn at home. A bra holds two clear domes against the breasts, tubing connects the domes to a small pump, and the pump maintains a gentle, steady vacuum for hours at a time. It is a wearable device, not a cream or a hand pump.
The idea is sustained, gentle mechanical tension: the vacuum creates a low, steady outward pull on breast tissue. EVEBRA is built on external tissue-expansion research led by Dr. Roger Khouri, who designed the BRAVA system that came before it. The explanation drawn from that research is that cells respond to sustained mechanical force, a process called mechanotransduction. A common analogy is orthodontics: gentle force applied steadily over months, not a short, strong burst.
Fit and seal
The bra holds the domes in place, and soft silicone rim skirts and a Skin Seal help form the seal. The standard system starts at a 30-inch underbust, so you measure first.
About 12 hours a day
A microprocessor-controlled pump maintains the low, steady vacuum, with no repeated hand-pumping. Many people choose overnight wear to reach the hours.
For 4 to 6 months
Change is gradual and depends on consistent wear. Timing and outcomes vary from person to person, and nothing is guaranteed.
Typical hand pumps use shorter sessions and stronger, intermittent suction, which may create temporary swelling. EVEBRA is designed for lower-level tension maintained across many hours of wear. There is an adjustment period, and it is a noticeable device rather than an invisible bra: loose or layered clothing helps. Persistent pain or irritation is a reason to stop and contact EVEBRA, not to push through.
Who should not use it
Do not use EVEBRA during pregnancy, while breastfeeding, or within three months after you stop breastfeeding. It is not for anyone with breast implants. If you have had implants removed, fat transfer, a biopsy, reconstruction or other breast surgery, or have another relevant medical condition, check with your surgeon or healthcare professional and contact the EVEBRA team before you start.
See the EVEBRA system →Check if it fits youProduct details in this section come from the EVEBRA product page (manufacturer information), read October 5, 2026.
Quick answers
Is fat transfer better than breast implants?
Neither is better for everyone. Implants add a device that needs lifelong monitoring; fat transfer uses your own tissue but suits smaller increases, and part of the fat does not survive.12
Do breast implants last forever?
No. FDA says breast implants are not considered lifetime devices, and complications become more likely the longer you have them.1
How much of transferred fat survives?
It varies. One review gave an example of about 100 cc surviving from a 140 cc injection,2 and a large series reported 266 ml of augmentation from 346 ml grafted per breast.3 These are examples, not guarantees.
Can fat transfer hide breast cancer on a mammogram?
A theoretical risk has been raised, but preliminary evidence does not support it.2 Tell your imaging team about any breast procedure you have had.
Where this comes from
- U.S. Food and Drug Administration. Risks and Complications of Breast Implants. Last updated Dec. 14, 2023.
- Chopra K, et al. Fat grafting breast augmentation mammaplasty. Eplasty 2013;13:ic55.
- Khouri RK, Khouri RK Jr, Rigotti G, et al. Aesthetic applications of Brava-assisted megavolume fat grafting to the breasts: a 9-year, 476-patient, multicenter experience. Plast Reconstr Surg 2014;133(4):796-807.
- EVEBRA. Product page and FAQ (manufacturer information), read Oct. 5, 2026. Components, protocol, fit, comfort and who should not use it.